IP Library Granted Patent US 8,206,977
Granted Patent B2
US 8,206,977 · App. 10/522,535 · Granted Jun 26, 2012

Tricistronic vectors and uses therefor

Assignee: MorphoSys AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,977
App. No.
10/522,535
Granted
Jun 26, 2012
Kind
B2
Abstract

A tricistronic vector (i.e., a vector capable of expressing three exogenous genes, which are not fused together, under the control of one promoter) effectively can encode an immunoglobulin-presenting polypeptide and two immunoglobulin (Ig) polypeptides. The encoded Ig-presenting polypeptide is able to associate with at least one of the Ig polypeptides via co-expressed associating agents. A vector according to the present invention particularly is suited for phage display technology, e.g., when the Ig-presenting polypeptide is a phage coat protein and the Ig polypeptides associate to form a Fab.

Claims (20)

1. A library of tricistronic prokaryotic display vector constructs comprising:

a regulatable prokaryotic promoter;

a first nucleic acid sequence encoding a gIIp phage coat protein or C-terminal domain thereof;

a second nucleic acid sequence encoding a first immunoglobulin (Ig) polypeptide;

a third nucleic acid sequence encoding a second immunoglobulin (Ig) polypeptide;

a nucleic acid sequence encoding a first associating agent fused to or comprised within said nucleic acid sequence encoding the gIIp phage coat protein or C-terminal domain thereof, wherein said first associating agent comprises a cysteine residue; and

a nucleic acid sequence encoding a second associating agent fused to or comprised within said nucleic acid encoding the first immunoglobulin (Ig) polypeptide, wherein said second associating agent comprises a cysteine residue,

wherein said first, second and third nucleic acid sequences are under the control of said promoter, and wherein upon expression of said tricistronic vector, (i) said gIIIp phage coat protein or C-terminal domain thereof and said first Ig polypeptide associate via their respective associating agents and (ii) said first and second Ig polypeptides self-associate.

2. The library of vector constructs according to claim 1 , wherein said first and second Ig polypeptides self-associate to form a Fab or other functional Ig fragment.

3. The library of vector constructs according to claim 1 , wherein the first and second Ig polypeptides self-associate via non-covalent interactions.

4. The library of vector constructs according to claim 1 , further comprising a first secretory signal sequence in the same reading frame as the nucleic acid sequence encoding the first Ig polypeptide.

5. The library of vector constructs according to claim 4 , further comprising a second secretory signal sequence in the same reading frame as the nucleic acid sequence encoding the second Ig polypeptide.

6. The library of vector constructs according to claim 5 , further comprising a third secretory signal sequence in the same reading frame as the nucleic acid sequence encoding the phage coat protein or C-terminal domain thereof.

7. The library of vector constructs according to claim 1 , wherein said vector is a phagemid vector.

8. The library of vector constructs according to claim 1 , wherein the associating agents become disassociated in solution upon the addition of a reducing agent.

9. The library of vector constructs according to claim 1 , wherein said second associating agent is fused to said first Ig polypeptide via a peptide linker.

10. The library of vector constructs according to claim 6 , wherein said first, second, and third secretory signal sequences are prokaryotic signal sequences.

11. The library of vector constructs according to claim 1 , further comprising a ribosome binding site positioned 5-primeward of the nucleic acid sequence encoding the second Ig polypeptide.

12. The library of vector constructs according to claim 11 , further comprising a ribosome binding site positioned 5-primeward of the nucleic acid sequence encoding the first Ig polypeptide.

13. The library of vector constructs according to claim 12 , further comprising a ribosome binding site positioned 5-primeward of the nucleic acid sequence encoding the phage coat protein or C-terminal domain thereof.

Assignments (2)
EXCERPT OF COMMERCIAL REGISTER REFLECTING NEW ADDRESS Recorded Apr 28, 2017
From: MORPHOSYS AG
To: MORPHOSYS AG
Reel/Frame 042357/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2005
From: PRASSLER, JOSEF; STARK, YVONNE
To: MORPHOSYS AG
Reel/Frame 016633/0679 →
Continuity (2)
Provisional Application 60399150 · Jul 30, 2002
Related Publication 20060121563A1 · Jun 8, 2006